Harel Insurance Investments & Financial Services’s Indaptus Therapeutics INDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4
| Closed | – | – | 717 |
|
|
2022
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 710 |
|
|
2022
Q3 | $0 | Sell |
4
-99
| -96% | – | ﹤0.01% | 721 |
|
|
2022
Q2 | $7K | Buy |
+103
| New | +$7K | ﹤0.01% | 680 |
|
|
2022
Q1 | – | Sell |
-106
| Closed | -$16K | – | 761 |
|
|
2021
Q4 | $16K | Hold |
106
| – | – | ﹤0.01% | 682 |
|
|
2021
Q3 | $25K | Buy |
+106
| New | +$25K | ﹤0.01% | 606 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 822 |
|
|
2020
Q4 | – | Sell |
-175
| Closed | -$99K | – | 751 |
|
|
2020
Q3 | $99K | Buy |
175
+11
| +7% | +$6.22K | ﹤0.01% | 397 |
|
|
2020
Q2 | $104K | Buy |
+164
| New | +$104K | ﹤0.01% | 326 |
|
|
2020
Q1 | – | Sell |
-164
| Closed | -$184K | – | 485 |
|
|
2019
Q4 | $184K | Sell |
164
-73
| -31% | -$81.9K | 0.01% | 212 |
|
|
2019
Q3 | $387K | Sell |
237
-42
| -15% | -$68.6K | 0.02% | 134 |
|
|
2019
Q2 | $2.71M | Buy |
279
+260
| +1,368% | +$2.53M | 0.14% | 62 |
|
|
2019
Q1 | $318K | Sell |
19
-266
| -93% | -$4.45M | 0.02% | 97 |
|
|
2018
Q4 | $4.81M | Sell |
285
-9
| -3% | -$152K | 0.3% | 55 |
|
|
2018
Q3 | $3.72M | Buy |
294
+281
| +2,162% | +$3.56M | 0.18% | 64 |
|
|
2018
Q2 | $132K | Buy |
+13
| New | +$132K | 0.01% | 228 |
|